https://www.pharmalive.com/wp-content/uploads/2022/12/handshake.jpg500623Christiane Truelovehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngChristiane Truelove2023-08-08 16:07:572023-08-08 16:13:41Pharma people on the move: Summer 2023 roundup
I-Mab quietly announced that its partner AbbVie is ending a Phase IB trial on lemzoparlimab for two types of cancers, despite a $2 billion deal inked in 2020.
https://www.pharmalive.com/wp-content/uploads/2022/04/BioSpaceAbbVie.jpg350625BioSpacehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngBioSpace2022-08-17 10:16:112022-08-17 10:16:11Despite $2B AML Deal, AbbVie Stops Early Cancer Combo Trial With I-Mab
